On 12 December 2024, a hybrid-format seminar will be held in Solna, Sweden, hosted by the Karolinska Institutet ↗. The event will spotlight innovative methods for identifying hormone-disrupting substances, aiming to foster dialogue and showcase cutting-edge research in the field of endocrine disruption. 

Lucia Vergauwen from the University of Antwerp ↗ will spotlight a key initiative within the PARC. Her presentation will delve into the development of Adverse Outcome Pathway-Network (AOP) approaches for assessing thyroid hormone system disruption. This research holds significant implications for regulatory hazard assessment, encompassing both human health and environmental safety. 

For more details, these are the links for the agenda ↗ of the seminar and the registration form ↗.